P/E of Supernus Pharmaceuticals, Inc.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. It offers Oxtellar XR, an extended-release oxcarbazepine for use in the treatment of epilepsy; and Trokendi XR, an extended-release topiramate, which is used for the treatment of epilepsy. The company??s product candidates comprise SPN-810, a molindone hydrochloride that is in Phase III clinical trial for the treatment of impulsive aggression in patients with attention deficit hyperactivity disorder (ADHD); and SPN-812, a viloxazine hydrochloride, which has completed Phase IIb trial that is used for the treatment of ADHD. It also develops SPN-809, a viloxazine hydrochloride, which is in Phase II ready clinical trial for the treatment of depression. The company markets its products through wholesalers and pharmaceutical distributors. Supernus Pharmaceuticals, Inc. was founded in 2005 and is based in Rockville, Maryland.
|ACTA Actua Corporation||NASDAQ > Technology > EDP Services||73.30%|
|BFS Saul Centers, Inc.||NYSE > Consumer Services > Real Estate Investment Trusts||73.33%|
|LPSN LivePerson, Inc.||NASDAQ > Technology > Computer Software: Prepackaged Software||73.35%|
|BCEI Bonanza Creek Energy, Inc.||NYSE > Energy > Oil & Gas Production||73.36%|
|KRG Kite Realty Group Trust||NYSE > Consumer Services > Real Estate Investment Trusts||73.41%|
|HTLD Heartland Express, Inc.||NASDAQ > Transportation > Trucking Freight/Courier Services||73.46%|
|SUPN Supernus Pharmaceuticals, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||73.51%|
|WF Woori Bank||NYSE > Finance > Commercial Banks||98,929.06%|
|SHG Shinhan Financial Group Co Ltd||NYSE > Finance > Major Banks||99,422.33%|
|CIB BanColombia S.A.||NYSE > Finance > Commercial Banks||271,056.66%|
|AVAL Grupo Aval Acciones y Valores S.A.||NYSE > Finance > Commercial Banks||289,792.65%|
|TLK PT Telekomunikasi Indonesia, Tbk||NYSE > Public Utilities > Telecommunications Equipment||731,941.22%|
|PRKR ParkerVision, Inc.||NASDAQ > Technology > Radio And Television Broadcasting And Communications Equipment||1,990,485.56%|